H Wu1, G Chen. 1. Zhongshan Ophthalmic Center, Sun Yat-sen University of Medical Sciences, Guangzhou 510060, China.
Abstract
PURPOSE: To evaluate the efficiency of Cyclosporine A and Thiotepa to decrease the postoperative recurrence rate of pterygium. METHODS:50 patients (50 eyes) with pterygium were treated withbare sclera resection and divided into two groups. One group used 1% cyclosporine A eye drops, the other group used 0.05% thiotepa eye drops. RESULTS: The average follow-up time is 10 months. The recurrence rate of cyclosporine group and thiotepa group is 5% and 10%. CONCLUSION:Cyclosporine A and Thiotepa can inhibit the hyperplasia of pterygium, and decrease the postoperative recurrence rate.
RCT Entities:
PURPOSE: To evaluate the efficiency of Cyclosporine A and Thiotepa to decrease the postoperative recurrence rate of pterygium. METHODS: 50 patients (50 eyes) with pterygium were treated with bare sclera resection and divided into two groups. One group used 1% cyclosporine A eye drops, the other group used 0.05% thiotepa eye drops. RESULTS: The average follow-up time is 10 months. The recurrence rate of cyclosporine group and thiotepa group is 5% and 10%. CONCLUSION:Cyclosporine A and Thiotepa can inhibit the hyperplasia of pterygium, and decrease the postoperative recurrence rate.
Authors: Magda Massae Hata Viveiros; Fabiano Yutaka Kakizaki; Laura Almeida Hércules; Carlos Roberto Padovani; João Manuel Grisi Candeias; Silvana Artioli Schellini Journal: Int Ophthalmol Date: 2015-08-11 Impact factor: 2.031